blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1569628

EP1569628 - NOVEL USE OF LYCOPENE FOR THE TREATMENT OF DISEASES ASSOCIATED WITH ANDROGEN SIGNALLING [Right-click to bookmark this link]
Former [2005/36]NOVEL USE OF LYCOPENE
[2009/18]
StatusNo opposition filed within time limit
Status updated on  28.05.2010
Database last updated on 03.09.2024
Most recent event   Tooltip07.10.2011Lapse of the patent in a contracting state
New state(s): CY, TR		published on 09.11.2011  [2011/45]
Applicant(s)For all designated states
DSM IP Assets B.V.
Het Overloon 1
6411 TE Heerlen / NL
[N/P]
Former [2005/36]For all designated states
DSM IP Assets B.V.
Het Overloon 1
6411 TE Heerlen / NL
Inventor(s)01 / BARELLA, Luca
Hofstetterstrasse 3
CH-4054 Basel / CH
02 / GORALCZYK, Regina
Allmendweg 7
79639 Grenzach-Wyhlen / DE
03 / SILER, Ulrich
Ruschbachstrasse 27
79639 Grenzach-Wyhlen / DE
04 / WERTZ, Karin
Bahnhofstrasse 68 A
79618 Rheinfelden / DE
 [2005/36]
Representative(s)Grossner, Lutz
DSM Nutritional Products Ltd. Wurmisweg 576
4303 Kaiseraugst / CH
[2005/36]
Application number, filing date03785727.304.12.2003
[2005/36]
WO2003EP13665
Priority number, dateEP2002002724406.12.2002         Original published format: EP 02027244
[2005/36]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2004052351
Date:24.06.2004
Language:EN
[2004/26]
Type: A1 Application with search report 
No.:EP1569628
Date:07.09.2005
Language:EN
The application published by WIPO in one of the EPO official languages on 24.06.2004 takes the place of the publication of the European patent application.
[2005/36]
Type: B1 Patent specification 
No.:EP1569628
Date:22.07.2009
Language:EN
[2009/30]
Search report(s)International search report - published on:EP24.06.2004
ClassificationIPC:A61K31/01, A61K31/07, A61K31/353, A61K31/375, A61P5/00
[2009/18]
CPC:
A61K31/355 (EP,US); A61K31/01 (EP,US); A61K31/375 (EP,US);
A61P13/08 (EP); A61P15/00 (EP); A61P15/04 (EP);
A61P15/12 (EP); A61P17/00 (EP); A61P3/04 (EP);
A61P3/10 (EP); A61P43/00 (EP); A61P5/00 (EP);
A61P5/28 (EP); A61P9/12 (EP) (-)
C-Set:
A61K31/01, A61K2300/00 (EP,US);
A61K31/355, A61K2300/00 (US,EP);
A61K31/375, A61K2300/00 (US,EP)
Former IPC [2005/36]A61K31/01, A61K31/07, A61K31/353, A61K31/375
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2005/36]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
TitleGerman:NEUE VERWENDUNG VON LYCOPIN ZUR BEHANDLUNG VON ERKRANKUNGEN IM ZUSAMMENHANG MIT ANDROGENWIRKUNG[2009/18]
English:NOVEL USE OF LYCOPENE FOR THE TREATMENT OF DISEASES ASSOCIATED WITH ANDROGEN SIGNALLING[2009/18]
French:NOUVELLE UTILISATION DU LYCOPENE POUR LE TRAITEMENT DE MALADIES ASSOCIÉES AUX ANDROGÈNES[2009/18]
Former [2005/36]NEUE VERWENDUNG VON LYCOPIN
Former [2005/36]NOVEL USE OF LYCOPENE
Former [2005/36]NOUVELLE UTILISATION DU LYCOPENE
Entry into regional phase28.04.2005National basic fee paid 
28.04.2005Designation fee(s) paid 
28.04.2005Examination fee paid 
Examination procedure22.06.2004Request for preliminary examination filed
International Preliminary Examining Authority: EP
28.04.2005Examination requested  [2005/36]
28.09.2005Despatch of communication of loss of particular rights: Claims {1}
09.12.2005Loss of particular rights, legal effect: Claims
13.12.2007Despatch of a communication from the examining division (Time limit: M06)
16.06.2008Reply to a communication from the examining division
07.07.2008Despatch of a communication from the examining division (Time limit: M04)
06.11.2008Reply to a communication from the examining division
01.12.2008Despatch of a communication from the examining division (Time limit: M03)
05.03.2009Reply to a communication from the examining division
23.04.2009Communication of intention to grant the patent
04.06.2009Fee for grant paid
04.06.2009Fee for publishing/printing paid
Opposition(s)23.04.2010No opposition filed within time limit [2010/26]
Fees paidRenewal fee
27.12.2005Renewal fee patent year 03
27.12.2006Renewal fee patent year 04
24.12.2007Renewal fee patent year 05
24.12.2008Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT22.07.2009
BE22.07.2009
CY22.07.2009
CZ22.07.2009
DK22.07.2009
EE22.07.2009
FI22.07.2009
NL22.07.2009
RO22.07.2009
SE22.07.2009
SI22.07.2009
SK22.07.2009
TR22.07.2009
BG22.10.2009
GR23.10.2009
PT22.11.2009
IE04.12.2009
LU04.12.2009
CH31.12.2009
LI31.12.2009
HU23.01.2010
[2011/44]
Former [2011/31]AT22.07.2009
BE22.07.2009
CZ22.07.2009
DK22.07.2009
EE22.07.2009
FI22.07.2009
NL22.07.2009
RO22.07.2009
SE22.07.2009
SI22.07.2009
SK22.07.2009
BG22.10.2009
GR23.10.2009
PT22.11.2009
IE04.12.2009
LU04.12.2009
CH31.12.2009
LI31.12.2009
HU23.01.2010
Former [2011/21]AT22.07.2009
BE22.07.2009
CZ22.07.2009
DK22.07.2009
EE22.07.2009
FI22.07.2009
NL22.07.2009
RO22.07.2009
SE22.07.2009
SI22.07.2009
SK22.07.2009
BG22.10.2009
GR23.10.2009
PT22.11.2009
IE04.12.2009
LU04.12.2009
CH31.12.2009
LI31.12.2009
Former [2010/49]AT22.07.2009
BE22.07.2009
CZ22.07.2009
DK22.07.2009
EE22.07.2009
FI22.07.2009
NL22.07.2009
RO22.07.2009
SE22.07.2009
SI22.07.2009
SK22.07.2009
BG22.10.2009
GR23.10.2009
PT22.11.2009
IE04.12.2009
CH31.12.2009
LI31.12.2009
Former [2010/46]AT22.07.2009
BE22.07.2009
CZ22.07.2009
DK22.07.2009
EE22.07.2009
FI22.07.2009
NL22.07.2009
RO22.07.2009
SE22.07.2009
SI22.07.2009
SK22.07.2009
BG22.10.2009
GR23.10.2009
PT22.11.2009
IE04.12.2009
Former [2010/25]AT22.07.2009
BE22.07.2009
CZ22.07.2009
DK22.07.2009
EE22.07.2009
FI22.07.2009
NL22.07.2009
RO22.07.2009
SE22.07.2009
SI22.07.2009
SK22.07.2009
BG22.10.2009
PT22.11.2009
Former [2010/23]AT22.07.2009
CZ22.07.2009
DK22.07.2009
EE22.07.2009
FI22.07.2009
NL22.07.2009
RO22.07.2009
SE22.07.2009
SI22.07.2009
SK22.07.2009
BG22.10.2009
PT22.11.2009
Former [2010/22]AT22.07.2009
CZ22.07.2009
DK22.07.2009
EE22.07.2009
FI22.07.2009
NL22.07.2009
RO22.07.2009
SE22.07.2009
SI22.07.2009
BG22.10.2009
PT22.11.2009
Former [2010/20]AT22.07.2009
DK22.07.2009
EE22.07.2009
FI22.07.2009
NL22.07.2009
SE22.07.2009
SI22.07.2009
BG22.10.2009
PT22.11.2009
Former [2010/17]AT22.07.2009
FI22.07.2009
NL22.07.2009
SE22.07.2009
SI22.07.2009
BG22.10.2009
PT22.11.2009
Former [2010/11]AT22.07.2009
FI22.07.2009
NL22.07.2009
SE22.07.2009
SI22.07.2009
Former [2010/10]AT22.07.2009
FI22.07.2009
NL22.07.2009
SE22.07.2009
Former [2010/09]AT22.07.2009
FI22.07.2009
SE22.07.2009
Former [2010/08]AT22.07.2009
SE22.07.2009
Cited inInternational search[X]WO0122958  (AVANSIS LTD [GB], et al) [X] 1-5,7,13-22,25-28,30,31 * page 7, line 22 - line 27 * * page 9, line 17 - line 26 *;
 [X]WO02058683  (LYCORED NATURAL PROD IND LTD [IL], et al) [X] 1,2,5,7,13,14,19,20,22,23,26-31 * page 6, line 17 - line 24; example 2 *;
 [X]US2002155163  (BENJAMIN SAMUEL D [US], et al) [X] 1-10,13-16,19-31 * claim 10 *;
 [X]DE10109798  (AVENTIS PHARMA GMBH [DE]) [X] 1-3,6-10,13-16,19-31 * paragraphs [0187] , [0188] *;
 [X]US2002001632  (REVEL CHASE [PA]) [X] 1,4-7,12-14,19,22,25-27,30,31 * paragraphs [0031] , [0035] *;
 [X]EP1314438  (NUTRICIA NV [NL]) [X] 1,4-7,12-14,18,19,22,25-27,30,31 * example 5 *
 [X]  - PARAN ESTHER ET AL, "Effect of tomato's lycopene on blood pressure, serum lipoproteins, plasma homocysteine and oxidative stress markers in grade I hypertensive patients", AMERICAN JOURNAL OF HYPERTENSION, Sixteenth Annual Scientific Meeting of the American Society of Hypertension;San Francisco, California, USA; May 15-19, 2001, (200104), vol. 14, no. 4 Part 2, ISSN 0895-7061, page 141A, XP002276573 [X] 1,5,7,13-16,19-31 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0895-7061(01)01854-4
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.